CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Brenner Martin sold 4,881 shares at $0.27 ($1,296)
- 4 Open-market sale Brenner Martin sold 5,267 shares at $0.30 ($1,592)
- 4 Open-market sale Brenner Martin sold 4,215 shares at $0.31 ($1,311)
- 4 Open-market sale Brenner Martin sold 5,011 shares at $0.31 ($1,529)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Brenner Martin sold 4,515 shares at an average $0.51 ($2,308)
- 4 Open-market sale Brenner Martin sold 47,020 shares at $0.59 ($27,521)
- 4 Grant or award Brenner Martin acquired 75,833 shares (grant or award)
- 4 Open-market sale Brenner Martin sold 4,184 shares at an average $0.68 ($2,849)
- 4 Open-market sale Brenner Martin sold 4,182 shares at an average $0.94 ($3,910)
- 4 Open-market sale Brenner Martin sold 4,382 shares at $1.20 ($5,258)
- 4 Grant or award Brenner Martin acquired 50,000 shares (grant or award)
Page 3 of 13 · 260 filings